BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 16, 2006
View Archived Issues
CE Mark for Tag-It Cystic Fibrosis Kit
Read More
ActivBiotics and Metaphore Pharmaceuticals complete merger
Read More
Pharmacopeia earns milestone payment in Organon collaboration
Read More
New multidose study of Riquent planned in lupus patients
Read More
Studies show BioThrax plus antibiotics protect animals post anthrax exposure
Read More
Japanese licensing deal for Fentanyl Taifun
Read More
Corautus Genetics to support study of VEGF-2 in critical limb ischemia
Read More
Salix offers development update
Read More
Duloxetine 60 mg once daily found safe and effective in fibromyalgia patients
Read More
GE-81112 factor B: A novel prokaryotic-specific protein synthesis inhibitor
Read More
Human Genome Sciences receives milestone for GSK-716155 IND filing
Read More
Mylan and Forest sign nebivolol agreement
Read More
Ablynx and Centocor sign Nanobodies agreement
Read More
Phase IIa study of ATL-1102 restarts
Read More
Safety data review in phase III study of Intercell's Japanese encephalitis vaccine
Read More
Russian approvals for HER-2 Protein AutoVac vaccine phase II trial
Read More
Placebo group assumptions correct in phase IIb study of VLTS-934 in intermittent claudication
Read More
Novel orally active CB1 receptor inverse agonist decreases food intake in rodents
Read More
Novel orally active and in vivo effective p38alpha MAPK inhibitors from Novartis
Read More
FDA issues guidance to improve efficiency of earliest stages of clinical testing
Read More
Recent patents report novel therapeutic agents for anxiety, depression, etc.
Read More
Novel possible treatment options for cancer disclosed in patent literature
Read More
First launch for Dong-A erectile dysfunction therapy
Read More